Page last updated: 2024-09-05

erlotinib hydrochloride and Orbital Neoplasms

erlotinib hydrochloride has been researched along with Orbital Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Sawy, T; Esmaeli, B; Glisson, BS; Kies, MS; Lippman, S; Myers, JN; Sabichi, AL; William, WN	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Orbital Neoplasms

Article	Year
Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:12 Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Epidermal Growth Factor; Erlotinib Hydrochloride; Female; Humans; Male; Orbital Neoplasms; Protein Kinase Inhibitors; Quinazolines	2012

Article

Year

Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.

Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:12

Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Epidermal Growth Factor; Erlotinib Hydrochloride; Female; Humans; Male; Orbital Neoplasms; Protein Kinase Inhibitors; Quinazolines

2012